tradingkey.logo

Zhengye Biotechnology Holding Ltd

ZYBT
1.850USD
+0.010+0.54%
Close 12/19, 16:00ETQuotes delayed by 15 min
87.26MMarket Cap
54.52P/E TTM

Zhengye Biotechnology Holding Ltd

1.850
+0.010+0.54%

More Details of Zhengye Biotechnology Holding Ltd Company

Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.

Zhengye Biotechnology Holding Ltd Info

Ticker SymbolZYBT
Company nameZhengye Biotechnology Holding Ltd
IPO dateJan 07, 2025
CEOHan (Aiden)
Number of employees277
Security typeOrdinary Share
Fiscal year-endJan 07
AddressNo.1 Lianmeng Street, Jilin Economic &
CityJILIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code132101
Phone
Websitehttps://www.jlzybio.com./
Ticker SymbolZYBT
IPO dateJan 07, 2025
CEOHan (Aiden)

Company Executives of Zhengye Biotechnology Holding Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Aiden Han
Mr. Aiden Han
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Ping Jiang
Mr. Ping Jiang
Independent Director
Independent Director
--
--
Mr. Zhongyao Liu
Mr. Zhongyao Liu
Chief Operating Officer, Chief Compliance Officer
Chief Operating Officer, Chief Compliance Officer
--
--
Mr. Jiayao Wu
Mr. Jiayao Wu
Independent Director
Independent Director
--
--
Mr. Wenbing (Christopher) Wang
Mr. Wenbing (Christopher) Wang
Independent Director
Independent Director
--
--
Mrs. Wenhua Sun
Mrs. Wenhua Sun
Director
Director
--
--
Mr. Ping Wang
Mr. Ping Wang
Chief Financial Officer
Chief Financial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Aiden Han
Mr. Aiden Han
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mr. Ping Jiang
Mr. Ping Jiang
Independent Director
Independent Director
--
--
Mr. Zhongyao Liu
Mr. Zhongyao Liu
Chief Operating Officer, Chief Compliance Officer
Chief Operating Officer, Chief Compliance Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2024
By BusinessUSD
Name
Revenue
Proportion
Swine vaccines
157.79M
84.67%
Poultry vaccines
15.51M
8.32%
Other vaccines
13.06M
7.01%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
186.36M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Swine vaccines
157.79M
84.67%
Poultry vaccines
15.51M
8.32%
Other vaccines
13.06M
7.01%

Shareholding Stats

Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Securingium Holding Ltd
84.40%
Han (Zhenfa)
6.25%
Dong (Yawen)
0.26%
Lian (Wei)
0.18%
He (Yuyou)
0.11%
Other
8.80%
Shareholders
Shareholders
Proportion
Securingium Holding Ltd
84.40%
Han (Zhenfa)
6.25%
Dong (Yawen)
0.26%
Lian (Wei)
0.18%
He (Yuyou)
0.11%
Other
8.80%
Shareholder Types
Shareholders
Proportion
Corporation
84.40%
Individual Investor
6.80%
Investment Advisor/Hedge Fund
0.11%
Investment Advisor
0.09%
Venture Capital
0.07%
Hedge Fund
0.06%
Other
8.47%

Institutional Shareholding

Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
9
420.54K
0.89%
+410.76K
2025Q2
10
43.29M
91.34%
+40.32M
2025Q1
9
43.23M
91.66%
+40.26M
2024Q4
1
2.96M
6.28%
+2.96M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Securingium Holding Ltd
40.00M
84.4%
+40.00M
--
Jan 07, 2025
Han (Zhenfa)
2.96M
6.25%
--
--
Jan 07, 2025
Dong (Yawen)
124.59K
0.26%
+124.59K
--
Jan 07, 2025
Lian (Wei)
83.06K
0.18%
+83.06K
--
Jan 07, 2025
He (Yuyou)
50.06K
0.11%
+50.06K
--
Jan 07, 2025
Invesco Capital Management LLC
36.84K
0.08%
+36.84K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
29.07K
0.06%
+20.62K
+244.20%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0.05%
Invesco Golden Dragon China ETF
Proportion0.05%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Zhengye Biotechnology Holding Ltd?

The top five shareholders of Zhengye Biotechnology Holding Ltd are:
Securingium Holding Ltd holds 40.00M shares, accounting for 84.40% of the total shares.
Han (Zhenfa) holds 2.96M shares, accounting for 6.25% of the total shares.
Dong (Yawen) holds 124.59K shares, accounting for 0.26% of the total shares.
Lian (Wei) holds 83.06K shares, accounting for 0.18% of the total shares.
He (Yuyou) holds 50.06K shares, accounting for 0.11% of the total shares.

What are the top three shareholder types of Zhengye Biotechnology Holding Ltd?

The top three shareholder types of Zhengye Biotechnology Holding Ltd are:
Securingium Holding Ltd
Han (Zhenfa)
Dong (Yawen)

How many institutions hold shares of Zhengye Biotechnology Holding Ltd (ZYBT)?

As of 2025Q3, 9 institutions hold shares of Zhengye Biotechnology Holding Ltd, with a combined market value of approximately 420.54K, accounting for 0.89% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -90.46%.

What is the biggest source of revenue for Zhengye Biotechnology Holding Ltd?

In FY2024, the Swine vaccines business generated the highest revenue for Zhengye Biotechnology Holding Ltd, amounting to 157.79M and accounting for 84.67% of total revenue.
KeyAI